MA56040A - Compositions comprenant des acides gras cétylés et leur utilisation dans le traitement de l'arthrite et des états inflammatoires articulaires - Google Patents

Compositions comprenant des acides gras cétylés et leur utilisation dans le traitement de l'arthrite et des états inflammatoires articulaires

Info

Publication number
MA56040A
MA56040A MA056040A MA56040A MA56040A MA 56040 A MA56040 A MA 56040A MA 056040 A MA056040 A MA 056040A MA 56040 A MA56040 A MA 56040A MA 56040 A MA56040 A MA 56040A
Authority
MA
Morocco
Prior art keywords
arthritis
compositions
treatment
fatty acids
inflammatory conditions
Prior art date
Application number
MA056040A
Other languages
English (en)
Inventor
Elisa Brilli
Andrea Lacorte
Germano Tarantino
Original Assignee
Alesco Srl
Pharmanutra S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl, Pharmanutra S P A filed Critical Alesco Srl
Publication of MA56040A publication Critical patent/MA56040A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
MA056040A 2019-05-27 2020-05-27 Compositions comprenant des acides gras cétylés et leur utilisation dans le traitement de l'arthrite et des états inflammatoires articulaires MA56040A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000007326A IT201900007326A1 (it) 2019-05-27 2019-05-27 Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari

Publications (1)

Publication Number Publication Date
MA56040A true MA56040A (fr) 2022-04-06

Family

ID=67957311

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056040A MA56040A (fr) 2019-05-27 2020-05-27 Compositions comprenant des acides gras cétylés et leur utilisation dans le traitement de l'arthrite et des états inflammatoires articulaires

Country Status (13)

Country Link
US (1) US12383525B2 (fr)
EP (1) EP3976184A1 (fr)
JP (1) JP7689083B2 (fr)
CN (1) CN114126581A (fr)
BR (1) BR112021022965A2 (fr)
CA (1) CA3140989A1 (fr)
IL (1) IL288269A (fr)
IT (1) IT201900007326A1 (fr)
MA (1) MA56040A (fr)
MX (1) MX2021014371A (fr)
SG (1) SG11202112774XA (fr)
UA (1) UA129569C2 (fr)
WO (1) WO2020240438A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT202100030170A1 (it) * 2021-11-29 2023-05-29 Pharmanutra S P A Cerotto transdermico, e uso di detto cerotto in un metodo di trattamento di un disturbo, o disordine, o patologia, di un tendine
IT202300004227A1 (it) * 2023-03-07 2024-09-07 Pharmanutra S P A Composizioni comprendenti acidi grassi cetilati e vitamina d, e loro usi relativi

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049824A (en) 1976-05-03 1977-09-20 Harry Weldon Diehl Cetyl myristoleate
US4393133A (en) 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
JPH0244806B2 (ja) * 1981-09-07 1990-10-05 Sunstar Kk Bitaminaoanteinihaigoshitanyukakeihifugaiyozaisoseibutsu
JP3860849B2 (ja) 1994-04-28 2006-12-20 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗動脈硬化治療剤
EP0679394B1 (fr) 1994-04-28 1998-01-14 Eisai Co., Ltd. Dérivé du Menatetrenome comme agent antiartériosclérotique
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
CA2222278C (fr) 1995-06-06 2008-05-13 Campbell Soup Company Complements alimentaires a base de mineraux pour repas dietetique
US5707670A (en) 1996-08-29 1998-01-13 The Procter & Gamble Company Use of bilayer forming emulsifiers in nutritional compositions comprising divalent mineral salts to minimize off-tastes and interactions with other dietary components
CU22723A1 (es) 1997-04-02 2002-02-28 Dalmer Lab Sa Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
NZ332959A (en) 1998-11-23 2001-09-28 Yasho Ind Pvt Ltd Preparation of cetyl myristate and cetyl palmitate
US6417227B1 (en) 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
US6361800B1 (en) 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
AU2001290367B2 (en) 2001-08-31 2008-06-19 Lypanosys Pte Limited Synthesis of ester linked long chain alkyl moieties
JP2003342159A (ja) 2002-03-18 2003-12-03 Nikko Chemical Co Ltd 皮膚老化防止化粧料
US7772279B2 (en) 2002-03-21 2010-08-10 Botanoceuticals, Inc. Use of vegetable butter-based cetyl myristoleate for treating osteoarthritis and other musculoskeletal disease conditions and injuries
GB0220182D0 (en) 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
AU2004224332A1 (en) 2003-03-20 2004-10-07 Imagenetix, Inc. Esterified fatty acid composition
AU2004287440A1 (en) 2003-10-28 2005-05-19 Emory University Dialysates and methods and systems related thereto
US20050100636A1 (en) 2003-11-10 2005-05-12 Megan Botteri [A Low-Calorie Sports Drink For Physically Active Women That is Fortified with Iron, Calcium and Essential Vitamins for Use in Rehydration and Replacing Electrolytes Lost During Periods of Physical Activity]
US7585527B2 (en) 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia
EP1790356A1 (fr) 2005-11-24 2007-05-30 Vifor (International) Ag Préparation contenant des complexes de fer(III) et des composés rédoxs
ES2634142T3 (es) 2005-12-23 2017-09-26 Ajay Gupta Composición de nutrición parenteral que contiene hierro
EP1978808B1 (fr) 2006-01-30 2018-08-29 Panion & BF Biotech Inc. Citrate de fer pour inverser, prévenir, retarder ou stabiliser la calcification des tissus mous
ITMI20080145A1 (it) 2008-01-30 2009-07-31 Pharmanutra S R L Uso di acido eicosapentanoico e/o docosaesanoico in donne con endometriosi
US20100021573A1 (en) 2008-07-22 2010-01-28 Michael J Gonzalez Compositions and methods for the prevention of cardiovascular disease
JPWO2010073642A1 (ja) 2008-12-25 2012-06-07 有限会社 アイ・ビー・イー 生物活性剤、医薬、化粧品、鮮度保持剤、および植物および動物の発育促進剤
CN102348482B (zh) 2009-01-12 2014-05-14 科学与工业研究委员会 用于制备顺式-9-十四碳烯酸十六烷基酯和顺式-10-十四碳烯酸十六烷基酯的方法
KR20100111040A (ko) 2009-04-06 2010-10-14 정시남 지방산 계열 화합물을 유효성분으로 함유하는 위장 질환 예방 또는 치료용 조성물
US8404745B2 (en) * 2011-03-16 2013-03-26 Raj R. Barathur Transdermal delivery of medicinal cetylated fatty esters using phonophoresis or iontophoresis
CN103687495A (zh) 2011-05-20 2014-03-26 弗里斯兰品牌有限公司 包含维生素k2的组合物
US20140121156A1 (en) 2011-06-13 2014-05-01 Entia Biosciences, Inc. Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention of associated comorbid states with the use of ergothioneine
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
WO2014160279A1 (fr) 2013-03-13 2014-10-02 Viroxis Corporation Formulations de crème stabilisées comprenant de l'essence de santal
US20140322314A1 (en) 2013-04-29 2014-10-30 Matinas Biopharma, Inc. Omega-3 Fatty Acid Formulations for Use as Pharmaceutical Treatment
EP2886129A1 (fr) 2013-12-20 2015-06-24 VitaK B.V. Prévention et action contraire de risque de thrombose induite par le régime alimentaire
EP3258924A2 (fr) 2015-02-20 2017-12-27 VitaK B.V. Statut en vitamine k et fonction capillaire
ITUB20153130A1 (it) 2015-08-14 2017-02-14 Pharmanutra S P A Acidi grassi cetilati, impianto per la loro preparazione e relativo uso
US9579357B1 (en) 2015-08-31 2017-02-28 Anc Products, Llc Therapeutic compositions
US10206949B2 (en) 2015-09-21 2019-02-19 Ofer Agam Composition that relieves heartburn, GERD and hangovers
US20170202802A1 (en) 2016-01-20 2017-07-20 Exeltis Usa, Inc. Compositions, kits and methods for nutrition supplementation
GB2552952B (en) * 2016-08-12 2020-03-04 Norbrook Lab Ltd Moxidectin topical liquid formulations
US11344575B2 (en) 2016-08-15 2022-05-31 Summit Innovation Labs, LLC Vascular calcification prevention and treatment
CN106343566A (zh) 2016-08-30 2017-01-25 李洋 一种慢性肾病患者用的特殊医用食品配方及其生产工艺
EP3632406B1 (fr) 2017-05-30 2024-03-13 The Nisshin OilliO Group, Ltd. Hydratant huileux et composition topique pour la peau le contenant
IT201700085412A1 (it) 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati

Also Published As

Publication number Publication date
MX2021014371A (es) 2022-02-21
WO2020240438A1 (fr) 2020-12-03
SG11202112774XA (en) 2021-12-30
US12383525B2 (en) 2025-08-12
IT201900007326A1 (it) 2020-11-27
CA3140989A1 (fr) 2020-12-03
CN114126581A (zh) 2022-03-01
US20220211655A1 (en) 2022-07-07
JP7689083B2 (ja) 2025-06-05
BR112021022965A2 (pt) 2022-01-04
EP3976184A1 (fr) 2022-04-06
JP2022544894A (ja) 2022-10-24
IL288269A (en) 2022-01-01
UA129569C2 (uk) 2025-06-04

Similar Documents

Publication Publication Date Title
EP3755805A4 (fr) Compositions et méthodes de traitement d'une hypoacousie non associée à l'âge chez un sujet humain
MA56107A (fr) Compositions comprenant une souche bactérienne lactobacillus paracasei et de l'acide hyaluronique et leur utilisation dans le traitement de la peau
EP3890747A4 (fr) Compositions pour le traitement de la fibrose et de l'inflammation
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
EP3796920A4 (fr) Compositions d'arnt/pré-miarn et leur utilisation dans le traitement du cancer
IL288269A (en) Compositions comprising cetylated fatty acids and use thereof in the treatment of arthritis and joint inflammatory conditions
EP3463304A4 (fr) Compositions comprenant du cannabidiol et de l'acide hyaluronique pour le traitement de maladies inflammatoires des articulations
EP3612215A4 (fr) Compositions et procédés pour le traitement d'inflammation pulmonaire
MA47688A (fr) Compositions utiles dans le traitement de l'amyotrophie spinale
MA40846A (fr) Compositions d'acides gras et d'esters d'acides gras auto-micellisantes, ainsi que leur utilisation dans le traitement d'états pathologiques
MA54456A (fr) Composés et leur utilisation dans le traitement d'une déficience en ?1-antitrypsine
EP3639833A4 (fr) Agent pour la prévention ou le traitement de maladies liées à la graisse et/ou de l'inflammation
MA52971A (fr) Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
EP3682240A4 (fr) Biomarqueurs et méthodes d'évaluation de risque d'infarctus du myocarde et d'infection grave chez des patients atteints de polyarthrite rhumatoïde
MA56392A (fr) Dérivés de 2h-indazole et leur utilisation dans le traitement de maladies
MA52961A (fr) Compositions et procédés pour la réduction ou le traitement d'une inflammation
EP3902524A4 (fr) Traitement de troubles cutanés avec des compositions comprenant un inhibiteur d'egfr
MA49794A (fr) Composition utilisée dans le traitement prophylactique et thérapeutique de troubles de l'appareil cardiovasculaire
EP3973060A4 (fr) Compositions utiles dans le traitement du syndrome de rett
MA55490A (fr) Mutéine de lipocaline pour le traitement de l'asthme
EP3905942A4 (fr) Formulation pour utilisation dans le traitement de l'arthrose
EP3768274A4 (fr) Composition destinée à être utilisée dans le traitement d'états provoqués par une déficience en calcium
MA56041A (fr) Compositions comprenant des acides gras cétylés, destinées à être utilisées dans le traitement de la muqueuse gastrique, du diabète et de l'hyperglycémie
EP4048245A4 (fr) Compositions de cannabidiol destinées à être utilisées dans le traitement de pathologies cardiaques
EP3638287A4 (fr) Méthodes et compositions pour le traitement d'une inflammation microbienne